Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2077 of 5804
-
Knee surgery showdown: button vs. screw for ACL graft fixation
Disease control Recruiting nowIn this randomized controlled trial the investigators will compare the results after primary anterior cruciate ligament (ACL) reconstruction using two different methods for femoral fixation of a bone-patellar tendon-bone (BPTB) autograft. Interference screws have been the standar…
Phase: NA • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for kids with resistant tumors? early trial tests CUDC-907
Disease control CompletedThis research study is evaluating a novel drug called CUDC-907 as a possible treatment for resistant (refractory) pediatric solid tumors (including neuroblastoma), lymphoma, or brain tumors.
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Global study aims to predict outcomes for rare skin lymphoma patients
Knowledge-focused Recruiting nowThe purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- an…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Massive study tests if new labor rules can cut C-Section rates safely
Disease control CompletedThis project is a clustered randomized controlled trial of a knowledge translation intervention of new ACOG guidelines for the diagnosis of poor progress in labor. The intent is to reduce the rate of cesarean section (CS) in first time mothers at term (\>= 37 weeks), with a verte…
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Knee surgery success may depend on bone alignment, study finds
Disease control OngoingThe investigators plan to perform a prospective observational cohort study of patients undergoing MPFL reconstruction for the treatment of episodic patellar instability in the absence of significant degenerative disease. The investigators will follow these study subjects for a mi…
Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New monitoring program aims to reduce repeat suicide attempts
Knowledge-focused CompletedVigilanS is an innovative healthcare program. Participants of this program are all patients leaving in the Nord-Pas de Calais region who survived a suicide attempt. General goals of the post hospitalization monitoring system for suicidal attempters are: * Standardize general he…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New chemo formula aims to boost transplant success in blood cancers
Disease control OngoingCaptisol Enabled Melphalan, is a new formulation of the standard of care melphalan chemotherapy that in packaged in an inactive substance that is believed to help the chemotherapy be more stable (meaning that it doesn't lose its effect or need to be administered quickly after bei…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New diabetes drug shows promise in chinese trial
Disease control CompletedThis study is designed as a prospective, multi-centre, parallel group, double-blind randomized, placebo-controlled, phase 3 clinical study to evaluate the efficacy and safety of MP-513 (Teneligliptin).
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Shoulder surgery showdown: which fix keeps the joint in place?
Disease control Recruiting nowRandomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinette (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New care model aims to speed up mental health help for teens
Disease control OngoingAmong youth, the prevalence of mental health and addiction (MHA) disorders is roughly 20%, yet youth are challenged to access services in a timely fashion. To address MHA system gaps, this study will test the benefits of an Integrated Collaborative Care Team (ICCT) model for at-r…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New cementless knee implant aims to improve mobility in osteoarthritis patients
Disease control OngoingThe primary objective of this study is to examine the change from pre-operative baseline to two year postoperative functional performance improvement for the ATTUNE primary, cementless TKA RP system as measured with the KOOS questionnaire (KOOS-ADL sub-score). This will be carrie…
Phase: NA • Sponsor: DePuy Orthopaedics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Laparoscopic vs open surgery: which is better for colon cancer recovery?
Knowledge-focused OngoingThe primary focus in this study is to investigate and improve the surgical technique. In addition the collection of clinical data during diagnostic and follow up and the collection of tumor and blood gives us the opportunity to investigate tumor biology and its relevance in terms…
Phase: NA • Sponsor: Haraldsplass Deaconess Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Could skipping the chest tube after lung surgery cut pain and hospital time?
Symptom relief TerminatedChest tubes are used routinely although preliminary studies demonstrate the feasibility and safety of intraoperative chest drain removal. Previous studies are however either retrospective or mainly concerning benign disease. Hypothesis: Participants treated without post-operativ…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New diabetes combo shows promise in chinese patients
Disease control CompletedThis study is designed as a prospective, multi-centre, parallel group, double-blind randomized, placebo-controlled, phase 3 clinical study to evaluate the efficacy and safety of MP-513 (Teneligliptin) in combination with metformin.
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can feedback reports close the kidney transplant racial gap?
Knowledge-focused CompletedThe purpose of the current study is to test a systems-level approach to disseminate a multicomponent, multilevel intervention consisting of educational materials about transplantation and the new kidney allocation system targeting dialysis facility medical directors, staff, and p…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New blood test may predict immunotherapy success in cancer patients
Knowledge-focused CompletedRecent scientific advances have shown the important role of immune system against cancer. Today, many immunological biotherapy like anti-PD1/PDL-1 are available in cancer treatment and generate durable clinical responses in some patients. The development of tools for monitoring a…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Can a tiny beacon make prostate radiation safer?
Disease control OngoingThe Calypso® System (Varian Medical Systems, Inc., Palo Alto, CA) is a recent technology using electromagnetic transponders implanted within the prostate. It is a real-time target tracking system that takes into account both inter- and intrafractional target motion. So the exact …
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Cancer drug tazemetostat gets Long-Term safety check in rollover trial
Disease control CompletedThis study will provide continuing availability to tazemetostat for people that have previously completed participation in a tazemetostat study, either with monotherapy (single drug treatment) or combination therapy. The aim of the study will be to assess the long-term safety of…
Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental combo targets Hard-to-Treat lung cancer
Disease control CompletedThe purpose of the study is to determine whether plinabulin (also known as BPI-2358) has an effect on cancer and body in combination with nivolumab, a standard treatment for metastatic squamous non-small cell lung cancer with progression on or after platinum-based chemotherapy. …
Phase: PHASE1 • Sponsor: Lyudmila Bazhenova, M.D. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Scientists map brain stimulation spots to ease Parkinson's symptoms
Knowledge-focused Recruiting nowThis protocol will characterize the effects of deep brain stimulation (DBS) location (both adverse and beneficial) on motor signs in people with Parkinson's disease (PD). This information can be used to inform future DBS protocols to tailor stimulation to the specific needs of a …
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC